Related Experiment Video

Updated: Jul 2, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Epothilones in breast cancer: current status and future directions

Francesco Atzori1, Monica Fornier

  • 1Department of Medical Oncology, Vall d'Hebron University Hospital, Passeig de la Vall d'Hebron, 08001 Barcelona, Spain. fatzori@vhebron.net

Expert Review of Anticancer Therapy
|August 14, 2008
PubMed

Insights

Epothilones, like ixabepilone, offer a new treatment option for breast cancer patients resistant to taxanes. Ongoing research aims to identify biomarkers for personalized epothilone therapy.

Area of Science:

  • Oncology
  • Pharmacology

Background:

  • Taxanes are a cornerstone in breast cancer treatment, but resistance is a significant clinical challenge.
  • Epothilones are a class of novel microtubule-stabilizing agents demonstrating efficacy in taxane-resistant tumors.

Purpose of the Study:

  • To review the clinical data and FDA approval of epothilones, specifically ixabepilone, for breast cancer treatment.
  • To discuss the potential integration of epothilones into breast cancer management and the ongoing search for predictive biomarkers.

Main Methods:

  • Review of clinical data and US FDA approval status of epothilones.
  • Discussion of ongoing and future randomized clinical trials.

Main Results:

  • Ixabepilone (Ixempra) received US FDA approval in October 2007 for advanced breast cancer post-prior therapies.
  • Clinical data support the efficacy of epothilones in patients who have progressed on taxanes and anthracyclines.

Conclusions:

  • Epothilones, particularly ixabepilone, represent a valuable therapeutic option for advanced breast cancer, especially in cases of resistance to standard chemotherapy.
  • Future research will define the role of ixabepilone in early and metastatic breast cancer, with a focus on biomarker discovery for patient selection.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...